* Insmed announces positive top-line results from phase 3 convert study of ALIS (amikacin liposome inhalation suspension) in adult patients with treatment-refractory nontuberculous mycobacterial (NTM) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback